# RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527

**Authors:** Thanaa A. El-Masry, Maysa M. F. El-Nagar, Nageh A. El Mahdy, Fatemah A. Alherz, Reham Taher, Enass Y. Osman

PMC · DOI: 10.3390/ph19010062 · Pharmaceuticals · 2025-12-29

## Full-text entities

- **Diseases:** Ehrlich Carcinoma (MESH:D002286)
- **Chemicals:** Sorafenib (MESH:D000077157), Lycopene (MESH:D000077276)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12771546/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12771546/full.md

---
Source: https://tomesphere.com/paper/PMC12771546